Focus on High-Risk DTC Patients-Reference-Cited by-同舟云学术

Focus on High-Risk DTC Patients

Published:2013-01 Issue:1 Volume:38 Page:18-24
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Piccardo Arnoldo,Arecco Federico,Puntoni Matteo,Foppiani Luca,Cabria Manlio,Corvisieri Stefania,Arlandini Anselmo,Altrinetti Vania,Bandelloni Roberto,Orlandi Fabio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference21 articles.

1. . Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.;Schlumberger;Eur J Endocrinol,2004

2. . Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.;Tuttle;Thyroid,2010

3. . Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.;Kim;J Clin Endocrinol Metab,2005

4. . Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer.;Polachek;J Endocrinol Invest,2011

5. . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.;Cooper;Thyroid,2009

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sufficiency of a Single Negative Thyroglobulin Standard for Judging the Success of Ablation in Low- and Intermediate-risk Differentiated Thyroid Cancer: A Retrospective Study;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08

2. Development and validation of a lung metastases-predicting nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients;FUTURE ONCOL;2024

3. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

4. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma;Endocrine;2024-05-29

5. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma;2024-03-06